Tag: Patient journey analysis

IR40

How is the Power of Patient Journey Mapping Transforming the Patient Experience?

patient journeyIn the face of limited resources and multiple priorities, healthcare organizations may question the value of improving and measuring the patient’s experience with care. Yet, regulatory trends and powerful healthcare market, combined with patient journey mapping, make a compelling case for improving the patient experience.

Recent research shows that any industry can benefit from mapping the customer’s journey, and the healthcare sector is no exception. The truth of the matter is, many healthcare companies provide excellent clinical care but fail when it comes to administrative experiences. By using patient journey mapping as a guide, healthcare marketers can implement processes and programs that deliver relevant and timely information and fill gaps that cause leakages in the patient experience. This practice can be helpful in improving pre- and post-clinical engagement, as well as further health initiatives of the population.

We at Quantzig, understand the predicaments healthcare companies face in providing a good patient experience. This is where patient journey mapping can help significantly but for patient journey mapping to be effective it is very important to understand which patient journey matters and why. And to help companies excel in the competitive healthcare industry, our team of experts has highlighted the benefits of patient journey mapping, challenges companies face in mapping patient journey, and a few important ways in which patient journey mapping can drive excellence and find indicators that are crucial to the patients.

Whether you are part of marketing, product development, or customer experience team at a hospital, a pharma company, a device manufacturer, or a health insurer, patient journey mapping should be part of your toolbox of customer research. If you would like to learn more about journey mapping, contact one of our experts today.

What is Patient Journey Mapping?

Patient journey mapping is an exercise that can be done by healthcare companies to better understand what individual patient experience throughout his/her journey. The patient journey map outlines all the patient touch points during every stage of the care journey and helps in creating strategic outreach that enhances patient engagement, satisfaction, and patient flow.

The patient journey typically consists of six stages:

  • Awareness
  • Help
  • Care
  • Treatment
  • Change in behavior or lifestyle
  • Ongoing Care or proactive Health

Using patient journey mapping as a guide, healthcare marketers can craft personalized and strategic outreach that keeps patients engaged throughout the care journey and encourages lasting patient-provider relationships.

Benefits of Patient Journey Mapping

Benefit #1: Helps in stopping care silos

Every healthcare company has blind spots that can occur anywhere, right from appointment scheduling to point-of-care to discharge and follow-up. When the workflow of the organization is mapped, these blind spots become more visible. These blind spots often lead to increased risk or a negative patient experience in some cases. Patient journey mapping can provide solutions to such issues.

Still, want to know more about the benefits of patient journey mapping? Request for more information here.

Benefit #2: Guide patient expectations

Patient journey mapping helps healthcare companies to solve one of the biggest problems that a patient faces, which is, not knowing what is supposed to happen next. The unknown or confusing instructions the patient receives during their journey creates a bad impact on the business. Furthermore, this leads to a lack of adherence to their care plan.

Benefit #3: Uncover pain points

Patient journey mapping can unveil pain points along the way. A better understanding of the different pain points that a patient has within the journey can help healthcare companies to create an opportunity for improvements in operations and keep a track of patient flow.

Benefit #4: Connect with patients emotionally

Understanding the patient journey allows companies to better empathize with the patients. Patient journey maps can illuminate the emotion of an encounter and highlight the feeling of the patient about an interaction. These insights provide a better understanding of the organization of how to connect with patients on an emotional level to meet their requirements.

Benefit #5: Make the care continuum continuous

When patients are referred outside of any healthcare organization, there is often a gap in communication between providers. These gaps could be a result of technology, geography, and network among other circumstances. As a result, often the care continuum does not feel continuous from the lens of the patient. This creates opportunities for gaps in care, thus, impacting overall patient outcomes, revenue, and the bottom line. This is where patient journey mapping can help.

Quantzig’s healthcare analytics solutions help clients in the healthcare industry including pharma, medical devices, diagnostics, and healthcare delivery companies to reduce costs, address key challenges, increase margins, and gain a competitive advantage in the market. Request a free proposal today to know more about the portfolio of services.

Benefit #6: Close-the-Loop

Communication breakdowns are at the core of most negative patient interactions. If the expectations of a patient are not communicated throughout the touchpoints on the patient journey, there are high chances that this expectation is not going to be met. Patient journey mapping can help in quickly identifying and resolving any patient issues. This can help in improving patient experience and create better efficiencies for your practice.

Benefit #7: Assists in continuous improvement

Collecting data of patient journey is important, but what matters the most is what you do with the data. Patient journey mapping helps in having the proper plan in place to examine this data regularly. Furthermore, this will help to understand recurring issues, systemic themes, and improvement opportunities.

Challenges in Patient Journey Mapping

Challenge #1: Investment

Healthcare companies to implement patient journey mapping into their process, need investment in terms of time and costs. This investment is required to capture the data from the current journey of the patients and their experience.

Challenge #2: Complexity of patient journey

Healthcare companies face the issue of complexity in the patient journey which makes it very difficult for them to know the point from where they should start mapping their patients. 

Challenge #3: Lack of proper skill set

Businesses may not have the appropriate skill set to capture the required patient data. This makes things even more difficult and challenging. Consequently, companies end up collecting useless or least valuable data and cannot obtain desired results.

Challenge #4: Regular monitoring of the patient outcomes

It needs to be updated and validated to keep up with constantly changing user needs, behaviors, technologies, and developments in an organization’s proposition. There may be pressures on the business to deliver customer initiatives that can be more readily measured in terms of impact on the bottom line.

We understand the challenges healthcare organizations face with the changing customer demographics in the healthcare spectrum. Our analytics solutions provide best-in-class frameworks to assist healthcare organizations to get maximum sales and marketing support and insights out of every customer relationship and interaction. Request a free demo below for more insights.

REQUEST A FREE DEMO FORM

IR22

3 Strategies for Leveraging Patient Journey Mapping to Improve Patient Experience

As patient experience moves towards the center stage for many of the nation’s health systems, leaders and pharmaceutical companies responsible for this function are tackling issues like lack of leadership to drive patient centricity, separating quality care from hospital amenities, and understanding patient journey, needs, and wants.

When a patient’s needs and demands are not understood or there is a breakdown in the communication, they feel lost, vulnerable, and afraid. This is where marketers and communicators should be contributing to the patient experience. While the healthcare professionals or pharmaceutical companies may not be able to change what happens in the examination room, there are several ways they can support and enhance communication throughout the experience, and patient journey mapping is a key strategy.

At Quantzig, we understand the power of patient journey mapping in boosting patient experience and the huge difference it can make in the growth graph of your healthcare business. And to help pharmaceutical companies excel in an ever-competitive healthcare Contact USmarket, our team of experts has highlighted three key strategies for leveraging patient journey mapping that can help pharmaceutical companies improve their patient experience.

Strategies for Leveraging Patient Journey Mapping to Improve Patient Experience

Strategy #1: Treat your organization’s website like the North Star

Pharmaceutical companies or any healthcare organization should ensure that their website should be truly patient-centric and offer clear, strategic calls-to-action to tap into the mindset of the patient. This helps your prospective patients to be just a click away from what they need. Patient journey mapping at the trigger event phase will likely drive the critical first impression and begin a positive or negative patient experience.

Strategy #2: Ensure your calls to action are an impeccable experience

Whether patients are calling for an appointment or scheduling services online, they should experience the ease of access. Lengthy hold times and arduous steps to see a provider creates friction for your patient audiences. Patient journey mapping at the cRequest Proposalonsideration phase pushes pharmaceutical companies to strive for improving the ease of access.

Strategy #3: Communicate to patients about the next step clearly

Ensuring that the patient understands the next step, and the step after that is very important. The intent and experience phase of patient journey mapping makes it mandatory for hospitals and pharmaceutical companies to have a clear communications protocol to guide patients through the scenario that may come next, making them feel well-cared for and delivering the utmost patient experience.


Wondering how to improve patient experience and reconfigure your approach to care? Patient journey mapping is the key. Request a free demo below and access patient data on real-time dashboards.

demo

IR33

Patient Journey Mapping for a Leading New Cancer Drugs Manufacturer Helps Form a Company-Wide Agreement on Key Issues and Unmet Needs

What the Client Wanted

A leading new cancer drugs manufacturer wanted to comprehend the regional unmet needs of the US and European patient population in the advanced stage of the disease and understand how they can be a respected player in the therapeutic area.Request Proposal

The Outcome

The company prioritized the list of unmet needs for the patient population and identified opportunities for promoters to share their resources with each other. This nurtured a company-wide agreement on key issues and unmet needs.


New Cancer Drugs Outlook

(more…)

Global-Interior-Design-Software-Market_T

Generic Drugs Patient Journey Analysis: A Quantzig Case Study

What the Client Wanted

A leading generic drugs manufacturer wanted to obtain and build an unbiased view of their patient segments to build stronger relationships by better understanding them on an emotional level and tailoring engagement strategies to their experiential disease journey.

The Outcome

Quantzig’s patient journey analysis created an inference between the generic drugs customer’s emotional experience, behavioral patterns, and their treatment experience. Request ProposalThe analysis also aided the client to identify appropriate intervention points in the form of digital channels and appropriate timing for specific types of content, particularly during sensitive times of the patient journey.


Generic Drugs Market Outlook

The global generic drugs manufacturing industry comprises firms primarily engaged in the development, manufacture, and marketing of generic drugs. The segment includes drugs from most of the therapeutic areas including cardiovascular drugs, nervous system drugs, and oncology drugs. One of the biggest catalyst of the generic drugs industry is the lower price of drugs when compared to the other branded drugs. Though generic drugs are chemically indistinguishable to their patented counterparts, they are usually sold at large discounts. This has enabled third-party payers and governments across the globe to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Additionally, factors such as an aging population, patent expiration of blockbuster innovator drugs, and an increasing prevalence of chronic diseases are driving the growth for generic drugs.


Industry Challenges

Commoditization and extensive reforms in both regulated and unregulated markets: Although new healthcare reforms have boosted sales of generic drugs in recent years, many governments across the globe are looking to reduce their expenses. Additionally, many countries have seen a dramatic change in their business model as payers become key stakeholders through the implementation of tenders.

Innovative technologies: An enduring issue for the pharmaceutical industry is how new technologies, predominantly digital-related technologies, have impacted the drug development and commercialization. Moreover, emerging technologies in pharmaceutical industry such as 3D printing and artificial intelligence are expected Request Solution Demoto impact the business models, workforce needs, operations, cybersecurity risks, and the supply chains of the generic drug manufacturing companies.


About the Client

The client – an American global specialty and generic drugs company headquartered in the US.

Client’s Challenge

The generic drugs manufacturer had outlined a new customer engagement approach for a mature asset in their health division. However, the success of the new approach was dependent on their ability to transform their brand into a trusted care partner in the eyes of the patient, as the patient manages a chronic condition. Drawing from a history of experience with their patient population, the client’s primary challenge was to obtain and build an unbiased view of their patient segments to build stronger relationships by better understanding them on an emotional level and tailoring engagement strategies to their experiential disease journey.


Summary of our patient journey analysis
To gain in-depth insights into our analytics solutions for the pharmaceutical industry

Contact US


Business Impact

Quantzig’s patient journey analysis helped the generic drugs manufacturer leverage primary market research in combination with digital engagement data to understand and measure the emotional journey and uncover key intervention points along the digital patient journey. Quantzig’s digital behavior analysts also worked in close collaboration with data scientists and client partners in the global pharmaceutical industry to identify appropriate digital data assets and markers that could serve as measurements for the patient emotional journey. This helped the client build customized behavioral taxonomies that were quantifiable within the digital footprints of the targeted patient segments. Furthermore, these custom taxonomies enabled the development of a comprehensive overview of market segments and a clear view of the intersection between a patient’s emotional journey and online digital behavior.

Patient Journey Analysis Insights

With the help of Quantzig’s patient journey analysis, establishments in the global pharmaceutical industry can create an inference between the generic drugs customer’s emotional experience, behavioral patterns, and their treatment experience. The patient journey analysis also helps companies identify appropriate intervention points in the form of digital channels and appropriate timing for specific types of content, particularly during sensitive times of the patient journey. Furthermore, generic drugs manufacturers can deploy more informed communication strategies to build stronger relationships with their target audience. Looking at the patient experience from a personal perspective enables the creation of more resonant content that speaks to this target market through the most appropriate digital channels in a way that is sensitive and effective.


To know more about how our patient journey analysis helped a leading generic drugs manufacturer

Request Solution Demo


Related Posts:

3

Patient Journey Analysis for a Pharmaceutical Industry Major Helps Identify Noteworthy Areas of Unmet Needs Across Multiple Patient Populations

What the Client Wanted

A leading pharmaceutical industry major wanted to understand their position in the current market and develop an optimal launch plan for new patient segments.

The Outcome

Gained insights on how to prioritize commercial activities based on the opportunities to impact the evaluation, treatment, and coverage decisions for each key stakeholder.

Summary of the Global Pharmaceutical Industry

The global pharmaceutical industry is responsible for the development, production, and marketing of medications to meet the rising needs of the customers across the globe. With mounting concerns pertaining to healthcare treatments, the pharmaceutical industry has witnessed a promising growth over the last five years and this trend is expected to continue in the coming years. Major factors driving the growth of the global pharmaceutical industry is the growing aging population, changing lifestyles, and unhealthy eating habits. Request ProposalMoreover, the positive influence of medication on global health, prosperity, and economic productivity is compelling players in this industry to heavily invest in R&D to further revolutionize the treatment process.


Industry Challenges

Intensifying customer expectations: Today, the pharma and healthcare environment is getting harsher with customers looking for cost restraints in the products being offered. Therefore, pharmaceutical industry players need to ensure that new therapies are clinically and economically better than the other alternatives. Besides, the rising number of illness cases is forcing players in the pharmaceutical industry to provide promising solutions with utmost quality.

Policy modifications: Any changes to the policies in the healthcare industry will have a direct impact on the pharmaceutical industry. With healthcare services being the top priority of the governments across the globe, leading organizations in the pharmaceutical industry are facing pressures to meet the adequate quality concerns set forth by the FDA.

Slower growth rate in emerging markets: Over the years, the reduction in the GDP of low-income and developing countries with high pharmaceutical growth prospects has prompted a corresponding decrease in the volume growth. However, unless these emerging markets pick up on their economic growth, the development of the pharmaceutical industry will prove to be difficult.


About the Client

A world leader in the pharmaceutical industry headquartered in the US. The company is a pioneer in developing and producing medicines and vaccines for a wide range of medical disciplines, including diabetology, cardiology, oncology, immunology, and neurology.

Client’s Challenge

The pharmaceutical industry players wanted to evaluate the potential impact of pursuing multiple future cardiology indications for label expansion. With its currently approved indications, the drug has reached maturity in its market, is exhibiting plateaued market performance, and facing multiple alternative treatment options. As a result, the pharmaceutical industry client wanted to conduct a patient journey analysis, understand the provider, payer, and patient perspectives that would help them fully understand the disease flow, treatment drivers and barriers, and key leverage points to impact therapy selection.


Summary of our patient journey analysis
To gain in-depth insights into our analytics solutions for the pharmaceutical industry

Request Solution Demo


Business Impact

With the help of Quantzig’s patient journey analysis, the pharmaceutical industry player incorporated multiple methodologies to develop a holistic, 360-degree patient journey, including:

  • Qualitative and quantitative research with providers, patients, and payers to uncover key factors that impact patient care and their relative influence
  • Mapping of the patient digital experience through a digital anthropology, patient roundtable virtual discussions, and reflective story-telling
  • Analysis of the Real World Evidence (RWE) data including EHR, claims, and utilization to uncover disparities in provider perceptions on behavior vs. actual clinical practice

The pharmaceutical industry player also identified noteworthy areas of unmet needs across multiple patient populations that represented a significant opportunity by layering primary and secondary research with health and behavioral data.

Patient Journey Analysis Insights

Quantzig’s patient journey analysis helps firms in the pharmaceutical industry to defined market segments based on specific unmet needs. This will further enable companies to develop deep engagement strategies for both physicians and patients. Furthermore, Quantzig’s multi-stakeholder and dimensional patient journey analysis approach helped the client discover and quantify the key transition points along the continuum of care for patients. Also, the client captured perceptions on different therapies in target patient populations and required evidence to change the standard of care.


To know more about how our patient journey analysis helped a leading pharmaceutical industry major

Request Solution Demo


Related Posts:

 

IR30

Patient Journey Analysis: A Case Study on How an Angiogenesis Inhibitors Drugs Manufacturer Validated the Efficacy of Their Clinical Trials

What the Client Wanted

Understand the drug performance in a real-world setting when compared to the ideal healthcare industry setting.

The Outcome

Created a validation framework to understand the effectiveness of clinical trials against real-world data.

Summary of the Angiogenesis Inhibitors Drugs Market

One of the key segments of cancer therapy is occupied by the angiogenesis inhibitors. The market for angiogenesis inhibitors is quite optimistic as they have emerged as the new targeted therapy for the cancer treatment. The molecules due to their specificity are gaining a lot of manufacturer’s interest. Additionally, with the dawn of new and improved technology, angiogenesis inhibitors therapy is witnessing a radical transitionRequest Proposal and is becoming more acceptable due to its site-specific approach. Furthermore, angiogenesis inhibitors drugs have become a critical component of a clinical treatment procedure for a variety of reasons.


Industry Challenges

  • Regulatory concerns: Today, firms in the healthcare industry have been forced to comply with the regulatory guidelines set forth by the governments across the globe. Additionally, with the fluctuating changes in regulatory requirements, it becomes necessary for angiogenesis inhibitors drugs manufacturers to stay relevant and keep-up-to-date with the regulatory changes and ensure that they meet all the mandates. 
  • Innovations: Intense competition in the global healthcare industry is increasing the need to stay relevant and keep pace with the latest developments for players. Moreover, developing angiogenesis inhibitors drugs is an expensive and time-consuming affair and requires high investments.

About the Client

A leader in the healthcare industry space and a leading manufacturer of angiogenesis inhibitors drugs based out of the United States.

Client’s Challenge

The client approached Quantzig to conduct a patient journey analysis to gain a 360° understanding of the patient journey, specifically for those patients who are diagnosed with cancer. With several manufacturing hubs spread across the world, the client also wanted to validate the efficacy of their clinical trials by understanding the ailment progression in patients under the influence of several therapies in the real-world setting. The client wanted to further understand the drug performance in the real world when compared to the ideal settings with the help of real-world data.

Summary of our patient journey analysis
To gain in-depth insights into our analytics solutions for the healthcare industry

Request Solution Demo


Business Impact

With the help of Quantzig’s patient journey analysis, the angiogenesis inhibitors drugs manufacturer created a validation framework to understand the effectiveness of clinical trials against real-world data based on the insights and findings from the patient journey. Additionally, the client gained actionable insights into the drug’s performance in the real world when compared to the ideal settings.

Patient Journey Analysis Insights

Quantzig’s patient journey analysis helps firms in the healthcare industry space to map the entire patient treatment path using data from the time of hospital admission, pharmacy information, laboratory test results, progress notes, and to discharge summaries.


To know more about how our patient journey analysis helped the angiogenesis inhibitors drugs manufacturer gain insights into the latest healthcare industry trends

Request Solution Demo


Related Posts:

photography work space on top view

Patient Journey Analysis for a Diabetes Drugs Manufacturer Helps Comprehend the Effectiveness of Clinical Trials Against Real World Data

The client: A diabetes drugs manufacturer

Area of engagement: Patient journey analysis

In terms of disease type, the diabetes drugs market has been segmented into type 1 diabetes, type 2 diabetes, gestational diabetes, and impaired glucose tolerance and impaired fasting glycemia. The accelerated pace of obesity amongst urban dwellers, improving access to healthcare, and rising disposable income are all expected to boost the growth prospects of the diabetes drugs market over the next few years. QZ- Request free proposalHowever, the supply market for diabetes drugs is highly fragmented with major players across the healthcare industry using various strategies such as new product launches, agreements, expansions, joint ventures, acquisitions, partnerships to increase their foothold in this market.

The Business Challenge

The client, a well-renowned diabetes drug manufacturer, headquartered in the US, wanted to gain a 360° understanding of the patient journey, specifically for those patients who are diagnosed with diabetes. The client wanted to understand the drug performance in the real world as compared to the ideal settings with the help of real-world data. They also wanted to validate the effectiveness of their clinical trials by understanding the ailment progression in patients under the influence of several therapies in the real-world scenario.

Want to learn more about how our patient journey analysis engagement helped the diabetes drugs manufacturer?

QZ- request a demo


The Solution Benefits and the Business Impact

Quantzig’s patient journey analysis solution helped the diabetes drugs manufacturer to gain insights into the drug’s performance in the real world when compared to the ideal settings. The solution also helped the client create a validation framework to understand the effectiveness of clinical trials against real-world data based on the insights and findings from the patient journey.

Patient Journey Analysis Predictive Insights

With the help of Quantzig’s patient journey analysis, firms in the healthcare industry can map the entire patient treatment path using data from hospital admission, patient demographics, laboratory test results, progress notes, pharmacy information, and discharge summaries.


Although the market is rapidly growing, there are a few major issues and challenges facing diabetes drugs manufacturers. Some of the factors include:

  • Innovations: The intense competition in the healthcare industry is increasing the need to stay relevant and keep pace with the latest developments for players. Moreover, developing diabetes drugs is an expensive and time-consuming affair and requires high investments.
  • Regulatory concerns: Lately, firms in the healthcare industry have been compelled to comply with the regulatory guidelines set forth by the governments across the globe. Additionally, with the fluctuating changes in regulatory requirements, it becomes necessary for diabetes drugs manufacturers to stay relevant and keep-up-to-date with the regulatory changes and ensure that they meet all the mandates.

To know more about how our patient journey analysis helped a leading diabetes drugs manufacturer

QZ- Get free info


Related Posts:

IR24

Patient Journey Analysis Helped a Renowned Dental Services Provider Enhance their Service Efficiency

The client: A renowned dental services provider

Area of engagement: Patient journey

The global dental services space is considered to be one of the fastest growing markets in the healthcare industry. Dental services at large comprise of diagnosis, prevention, and treatment of diseases concerned with the oral activity. The growth of the dental services space can be attributed to the rising number of people suffering from periodontal disease, growing private health insurance coverages, and escalating demand for cosmetic dentistry. Additional factors such as rising geriatric population, changing lifestyles, and increasing incidences of dental caries will spur the adoption of dental services among the populace.

Here are some of the factors influencing the growth of the dental services space:

  • Aging population: According to recent statistics, it is estimated that the number of elderly people in the United States grew at a rate of 15% over the last decade. This has subsequently resulted in the need for treating illnesses such as loose dentures and oral complications.
  • Rising healthcare costs: In the recent years, healthcare costs, especially in the dental services sector, have increased owing to a considerable rise in the number of patients. Consequently, organizations have been forced to improve their technological capabilities to bridge the gap for reliable and affordable services. Moreover, the rising government initiatives to offer low-cost services to the customers are compelling businesses to meet the demands of the customers.

To address such challenges and assess the growing demands for dental services, organizations are leveraging patient journey analysis solutions. Patient journey analysis helps patients gain a deeper understanding of the healthcare process. Moreover, the solution also allows businesses to bolster their health outcomes and uncover opportunities.QZ- Request free proposal

The Business Challenge

The client, a renowned dental services provider, wanted to gain a better understanding of the patient’s journey in the healthcare system. With the help of Quantzig’s patient journey analysis, the client wanted to understand the patient’s responsiveness to the medications and further improve the quality of care and release resources. Moreover, with the help of our solution, the dental services provider wanted to devise strategies to monitor the patient’s effectively and gain end-to-end visibility into the healthcare system. The primary objective of the client was to understand the patient’s experience and maximize the quality and efficiency of clinical management.

QZ- patient journey

 Want to learn more about our analytics solutions?

QZ- request a demo


Patient Journey Analysis Solution Benefits

Strategies that we recommend to improve healthcare efficiency and enhance the ROI

The patient journey analysis solution offered by Quantzig helped the dental services provider better engage with patients and understand their individual needs and challenges. The solution further allowed the client to implement new drug discovery projects and explore robust commercialization strategies to help patients’ meet their own health goals. The patient journey analysis also allowed the dental services provider to gain an accurate picture of physicians prescribing behavior, treatment regimens, and the flow of the treatment.

Patient Journey Analysis Predictive Insights

The patient journey analysis solution offered by Quantzig assisted the dental services provider to interact with the patients effectively and allocate their resources to meet patients’ requirements. The client was able to identify the gaps in the treatment patterns and efficiently diagnose and improve the treatment patterns.


Want to know more about our approach to patient journey?

QZ- Get free info


Related posts: